New Danish registry data confirm the safety of switching to infliximab biosimilars, showing low rates of serious adverse ...

All Things Biosimilars: How Streamlined CES Rules Could Shift the Market ...

All Things Biosimilars: How Streamlined CES Rules Could Shift the Market ...

All Things Biosimilars: How Streamlined CES Rules Could Shift the Market ...

All Things Biosimilars: How Streamlined CES Rules Could Shift the Market ...

All Things Biosimilars: How Streamlined CES Rules Could Shift the Market ...

Mayo Clinic’s Chelsee Jensen, PharmD, discusses FDA policy changes, biosimilar development hurdles, denosumab lessons, and ...

After much anticipation, the FDA approves the first interchangeable biosimilar, which is hoped to bring down the high cost of insulin. The FDA has approved Biocon Biologic's Semglee insulin glargine ...

The FDA has approved Ahzantive (aflibercept-mrbb) as the third biosimilar referencing Eylea (aflibercept) for the treatment of eye conditions, including age-related macular degeneration. Formycon and ...

While the Trump administration’s latest executive order touts sweeping drug price cuts through international benchmarking, the broader pharmaceutical pricing crisis in the US reveals a far more ...

Bevacizumab-bvzr…pegfilgrastim-bmez…infliximab-axxq…. Have you ever wondered what is behind the seemingly random letter strings attached to the nonproprietary names (also known as “proper names”) of ...

Tofidence, a tocilizumab biosimilar developed by Biogen, will be used to treat rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, and systemic juvenile idiopathic arthritis. The FDA ...